IQVIA HOLDINGS INC. Increase (Decrease) in Unbilled Receivables
IQVIA HOLDINGS INC. (IQV) reported Increase (Decrease) in Unbilled Receivables of $338.00 million for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-10-25.
Discontinued › Notes
us-gaap:IncreaseDecreaseInUnbilledReceivables · last filed 2018-10-25
- IQVIA HOLDINGS INC. increase (decrease) in unbilled receivables for the quarter ending 2018-09-30 was $112.00M.
- IQVIA HOLDINGS INC. increase (decrease) in unbilled receivables for the quarter ending 2018-06-30 was $77.00M.
- IQVIA HOLDINGS INC. increase (decrease) in unbilled receivables for the quarter ending 2018-03-31 was $149.00M.
| Period end | Increase (Decrease) in Unbilled Receivables 3 month | Increase (Decrease) in Unbilled Receivables 6 month | Increase (Decrease) in Unbilled Receivables 9 month |
|---|---|---|---|
| 2018-09-30 | $112.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-25 | $189.00M derived: sum of 2 quarters · filed 2018-10-25 | $338.00M 10-Q · filed 2018-10-25 |
| 2018-06-30 | $77.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-27 | $226.00M 10-Q · filed 2018-07-27 | |
| 2018-03-31 | $149.00M 10-Q · filed 2018-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |